The in vivo contract research organization sector is witnessing significant expansion as pharmaceutical and biotechnology companies continue to increase investments in drug discovery, preclinical testing, and advanced therapeutic development. Rising demand for outsourced research services, combined with growing pressure to accelerate clinical pipelines, has strengthened the role of specialized...